Trileptal and Lamisil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Trileptal (oxcarbazepine) and Lamisil (terbinafine hydrochloride). Common drug interactions include chronic kidney disease among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Trileptal and Lamisil. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Trileptal?

Trileptal has active ingredients of oxcarbazepine. It is often used in bipolar disorder. eHealthMe is studying from 23,558 Trileptal users. Check the latest studies of Trileptal.

What is Lamisil?

Lamisil has active ingredients of terbinafine hydrochloride. It is often used in pulmonary aspergilloma (mycetoma). eHealthMe is studying from 14,080 Lamisil users. Check the latest studies of Lamisil.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

35 people who take Trileptal and Lamisil together, and have interactions are studied.

Trileptal and Lamisil drug interactions.

What are the common drug interactions of Trileptal and Lamisil, by gender? *:

female:

Chronic kidney disease
Renal injury (kidney injury)
Haematochezia (passage of stools containing blood)
Renal failure (kidney dysfunction)
Death

male:

Headache (pain in head)
Fall
Contusion (a type of hematoma of tissue in which capillaries)
Depression
Dry mouth
Hypermetabolism (abnormal increase in the body's basal metabolic rate)
Injury
Joint injury
Migraine (headache)
Physical assault

What are the common drug interactions of Trileptal and Lamisil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Aspartate aminotransferase increased
Blood creatine phosphokinase increased
Muscle spasms (muscle contraction)
Pain in extremity
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)

10-19:

n/a

20-29:

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)

30-39:

Bacteriuria (presence of bacteria in urine)
Bedridden
Blood alkaline phosphatase decreased
Blood calcium decreased
Blood chloride increased
Blood creatinine decreased
Blood urea decreased
Carbon dioxide decreased
Cystitis (inflammation of the wall of the bladder)
Gait disturbance

40-49:

Hypertension (high blood pressure)

50-59:

Dry mouth
Fall
Hypermetabolism (abnormal increase in the body's basal metabolic rate)
Injury
Joint injury
Migraine (headache)
Physical assault
Road traffic accident
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Snoring

60+:

Chronic kidney disease
Renal injury (kidney injury)

What are the existing conditions these people have? *

Pain: 26 people, 74.29%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 8.57%
Nail Tinea (fungal infection of nail): 2 people, 5.71%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Trileptal and Lamisil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously